This didn’t make any headlines.
The city of Itajai, Brazil offered Ivermectin to its citizens during the COVID pandemic. The results were spectacular. Hospitalizations and deaths were cut in half.
Source: Zero Hedge reported:
Early on in the pandemic, before the vaccines were available, the Southern Brazilian city of Itajai offered Ivermectin as a prophylaxis against the disease.
Between July and December of 2020, roughly 220,000 people were offered a dose of 0.2mg/kg/day (roughly 18mg for a 200lb person) as an optional treatment for 2 days, once every two weeks.
133,051 people took them up on it, while 87,466 did not.
After analyzing the data, a team of researchers spanning several Brazilian institutes, the University of Toronto, and Columbia’s EAFIT concluded in a December pre-print study that hospitalization and mortality rates were cut in half over the seven-month period among the Ivermectin group.
The Brazilian city of Itajai has offered Ivermectin as prophylaxis (0.2mg/day/kg for 2 days every 2 weeks) to its 220,000 inhabitants and meticulously tracked the results.— Covid19Crusher (@Covid19Crusher) December 11, 2021
60% (with higher risk) took IVM over 7 months.
The Covid hospitalization and mortality rates were HALVED. pic.twitter.com/94fheTfwzm